000 01536 a2200397 4500
005 20250515002641.0
264 0 _c20060123
008 200601s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2005.08.037
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVasdev, Neil
245 0 0 _aSynthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cDec 2005
300 _a5270-3 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCarbon Radioisotopes
650 0 4 _aGlycogen Synthase Kinase 3
_xanalysis
650 0 4 _aGlycogen Synthase Kinase 3 beta
650 0 4 _aIsotope Labeling
650 0 4 _aPositron-Emission Tomography
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aThiazoles
_xchemical synthesis
650 0 4 _aTissue Distribution
650 0 4 _aUrea
_xanalogs & derivatives
700 1 _aGarcia, Armando
700 1 _aStableford, Winston T
700 1 _aYoung, Alex B
700 1 _aMeyer, Jeffrey H
700 1 _aHoule, Sylvain
700 1 _aWilson, Alan A
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 15
_gno. 23
_gp. 5270-3
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2005.08.037
_zAvailable from publisher's website
999 _c15832667
_d15832667